These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1790722)

  • 1. Antibiotic susceptibility and outer membrane proteins of clinical Xanthomonas maltophilia isolates.
    Cullmann W
    Chemotherapy; 1991; 37(4):246-50. PubMed ID: 1790722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
    Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
    APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.
    Lecso-Bornet M; Pierre J; Sarkis-Karam D; Lubera S; Bergogne-Berezin E
    Antimicrob Agents Chemother; 1992 Mar; 36(3):669-71. PubMed ID: 1622183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of cyclic nucleotides on beta-lactamase production and outer membrane proteins of clinical Xanthomonas maltophilia isolates].
    Cullmann W
    Immun Infekt; 1991 Feb; 19(1):3-7. PubMed ID: 1648031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
    Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T
    Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer membrane protein profiles of Xanthomonas maltophilia isolates displaying temperature-dependent susceptibility to gentamicin.
    Wilcox MH; Winstanley TG; Spencer RC
    J Antimicrob Chemother; 1994 Mar; 33(3):663-6. PubMed ID: 8040133
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results.
    Hohl P; Frei R; Aubry P
    Diagn Microbiol Infect Dis; 1991; 14(5):447-50. PubMed ID: 1797460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of ceftazidime and aztreonam resistance from nosocomial strains of Xanthomonas (Stenotrophomonas) maltophilia to a recipient strain of Pseudomonas aeruginosa ML-1008.
    Babálová M; Blahová J; Lesická-Hupková M; Krcméry V; Kubonová K
    Eur J Clin Microbiol Infect Dis; 1995 Oct; 14(10):925-7. PubMed ID: 8605913
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones.
    Daikos GL; Lolans VT; Jackson GG
    Antimicrob Agents Chemother; 1988 May; 32(5):785-7. PubMed ID: 3134852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin.
    Legakis NJ; Tzouvelekis LS; Makris A; Kotsifaki H
    Antimicrob Agents Chemother; 1989 Jan; 33(1):124-7. PubMed ID: 2496655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility of Stenotrophomonas (Xanthomonas) maltophilia: comparative (NCCLS criteria) evaluation of antimicrobial drugs with the agar dilution and the agar disk diffusion (Bauer-Kirby) tests.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(3):164-73. PubMed ID: 9612606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
    Cook PP; Das TD; Gooch M; Catrou PG
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth temperature-dependent variation of cell envelope lipids and antibiotic susceptibility in Stenotrophomonas (Xanthomonas) maltophilia.
    Rahmati-Bahram A; Magee JT; Jackson SK
    J Antimicrob Chemother; 1995 Aug; 36(2):317-26. PubMed ID: 8522461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of media composition on the susceptibility of Xanthomonas maltophilia to beta-lactam antibiotics.
    Bonfiglio G; Livermore DM
    J Antimicrob Chemother; 1991 Dec; 28(6):837-42. PubMed ID: 1816181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone supersusceptibility mediated by outer membrane protein OprH overexpression in Pseudomonas aeruginosa: evidence for involvement of a nonporin pathway.
    Young M; Hancock RE
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2365-9. PubMed ID: 1336943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.
    Hancock RE
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S93-9. PubMed ID: 9710677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility of clinical isolates to aztreonam].
    Nagasawa Z; Nishimura T; Nagumo F; Ueda H; Tadano J; Katoh O; Yamada H
    Jpn J Antibiot; 1989 Jun; 42(6):1257-70. PubMed ID: 2507799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lipopolysaccharide anionic binding sites in aminoglycoside uptake in Stenotrophomonas (Xanthomonas) maltophilia.
    Vanhoof R; Sonck P; Hannecart-Pokorni E
    J Antimicrob Chemother; 1995 Jan; 35(1):167-71. PubMed ID: 7768765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS; Mazens-Sullivan MF; Bartlett RC
    Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.